Literature DB >> 8793495

Immunohistological localization of tenascin in the human endometrium.

M Yamanaka1, M Taga, H Minaguchi.   

Abstract

Tenascin (TN) is an extracellular matrix glycoprotein that seems to be involved in embryogenesis, carcinogenesis and wound healing. In order to clarify the biological significance of TN in the human endometrium, we investigated its expression in the normal as well as in the hyperplastic and neoplastic human endometrium, using immunohistochemistry. We also investigated the coexistence of TN with proliferating cell nuclear antigen (PCNA), a marker of cell proliferation, in endometrial carcinoma to further assess the involvement of TN in regulating cell proliferation. TN expression was observed in the stroma surrounding the endometrial gland in the proliferative phase, whereas it could not be found in the secretory phase. The localization of TN and PCNA coincided frequently, as the stromal portion where the expression of TN was observed always showed positive for PCNA. These results suggest that TN is involved in cell proliferation and carcinogenesis in the human endometrium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793495     DOI: 10.1159/000292279

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  The change in tenascin expression in mouse uterus during early pregnancy.

Authors:  H Kida; M Taga; H Minaguchi; M Hanazono; T Ohashi; T Sakakura; M Kusakabe
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

2.  Bioengineering strategies of the uterus towards improving current investigative models and female reproductive health.

Authors:  H Campo; I Cervelló; A Pellicer
Journal:  Facts Views Vis Obgyn       Date:  2019-03

3.  A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo.

Authors:  Alberto Dal Corso; Rémy Gébleux; Patrizia Murer; Alex Soltermann; Dario Neri
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.